BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, June 7, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 9, 2010
View Archived Issues
CD34 marker suggests sunitinib targets tumor vasculature in clear cell renal cell carcinoma
Read More
Eosinophil cationic protein identified as new biomarker for coronary artery disease
Read More
New dipeptidyl peptidase 4 inhibitors discovered by Cadila Pharmaceuticals
Read More
New nonopioid analgesics claimed by Elder Pharmaceuticals
Read More
Arena Pharmaceuticals and Merck & Co. claim new GPR81 agonists
Read More
Preclinical pharmacology of Lexicon Pharmaceuticals' S1PL inhibitors described
Read More
Merck & Co. selects new lead NK1 antagonist for further evaluation
Read More
Leptin therapy proves advantageous in mouse model of type 1 diabetes
Read More
Merck & Co.'s new BB3 agonist reduces weight in obesity model
Read More
Achaogen discloses novel carbacephems
Read More
New mitochondrial F1F0 ATPase hydrolase inhibitors claimed by U.S. scientists
Read More
AnaptysBio collaborates with VLST to generate novel antibody therapeutics
Read More
Health Canada approves Seasonique contraceptive
Read More
Tioga receives SPA agreement from FDA for phase III asimadoline trials in D-IBS
Read More
Seattle Genetics, Takeda and Millennium begin phase III trial of brentuximab vedotin
Read More
Crucell and GSK collaborate to develop second-generation malaria vaccine
Read More
Inovio completes enrollment in phase I VGX-3100 cervical cancer vaccine trial
Read More
MAP Pharmaceuticals begins pharmacodynamics trial of Levadex migraine therapy
Read More
Swedish Orphan Biovitrum and LFB launch Willfact in Germany for von Willebrand's disease
Read More
Sanofi-aventis obtains exclusive worldwide license for new regenerative diabetes therapeutic
Read More
King Pharmaceuticals begins phase IIb Eladur trial in chronic low back pain
Read More
FDA to review Abbott's diagnostic test for acute kidney injury risk
Read More
Hemispherx Biopharma to study Alferon N Injection for hospitalized influenza patients
Read More
Calistoga begins phase I combination trial of CAL-101 in non-Hodgkin's lymphoma and leukemia
Read More
CytRx begins phase II bafetinib trial in advanced prostate cancer
Read More
Synairgen starts phase II trial of inhaled IFN-beta in asthma caused by respiratory viruses
Read More
